Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein O-like pseudogene (ENSG00000248493) is an unprocessed pseudogene that resembles the gene for apolipoprotein O but contains mutations—such as frameshifts or premature stop codons—that abrogate protein-coding potential[2][1]. Pseudogenes typically arise from duplication, retrotransposition, or disabling mutations, and are generally considered non-functional genomic elements[2]. Some pseudogenes may be transcribed as RNA, occasionally exerting regulatory roles, but there is no evidence that this specific pseudogene is active or contributes to disease or serves as a drug target[2][3]. This entry should not be considered a legitimate molecular drug target or therapeutic receptor, and is present in genomic databases primarily for annotation completeness, not for functional or translational research purposes[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein O-like pseudogene.